Larney, Sarah

Ph.D.

Principal scientist

Centre de recherche du CHUM

Research theme

Assistant Professor
Department of Family Medicine and Emergency Medicine, Université de Montréal

Contact

sarah.larney@umontreal.ca
514-890-8000, ext.: 20639

Twitter

The patient who needs immediate assistance should not communicate directly with the researcher. Instead, they should call the doctor’s office or take other appropriate measures, such as going to the nearest emergency service.

Other affiliations

Adjunct Senior Research Fellow
National Drug and Alcohol Research Centre, University of New South Wales

Research Associate
Brown University

Keywords

Injection drug use
People who inject drugs
Opioid agonist therapy
Hepatitis C
Mortality
Older people who use drugs

Research interests

Dr Larney’s work focuses on the epidemiology and prevention of drug-related harms such as hepatitis C infection, injecting-related injuries and diseases (e.g. abscesses), excess mortality, and contact with the criminal legal system. She is developing a program of research on aging in people who use drugs. Current projects include :

  • a rapid assessment of the impacts of COVID-19 on people who inject drugs
  • a rapid systematic review of the effects of “Big Events” such as natural disasters, economic recessions and pandemics on people who use drugs and delivery of harm reduction and drug treatment services
  • analysis of mortality in the Hepco cohort of people who inject drugs. This is a long-standing prospective cohort study with linkage to administrative deaths data. We aim to assess patterns and changes over time in causes of death, with a particular focus on understanding the influence of unstable housing on mortality outcomes.

Publications

PubMed

News

Covid-19 is worse for drug users: survey